Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Background Data on the efficacy of transcatheter edge-to-edge repair (TEER) in patients
with cardiogenic shock (CS) are limited. Objectives This study investigated the …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, results in reduced quality of life, heart failure, and increased mortality. Mitral valve …

Despite the rapidly evolving evidence base in modern cardiology, progress in the area of
cardiogenic shock remains slow, with short-term mortality still reaching 40-50%, relatively …

Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …

Background COAPT-trial entry criteria are useful to identify patients with better outcomes
after transcatheter edge-to-edge repair (TEER). However, up to one-half of real-world …

Background Functional mitral regurgitation (MR) is an important clinical consideration in
patients with heart failure. Transcatheter edge-to-edge repair (TEER) has emerged as a …

Aims Cardiogenic shock (CS) is a state of low cardiac output resulting in end-organ
hypoperfusion. Despite high in-hospital mortality rates, little evidence exists regarding the …